Protagenic Therapeutics, Inc.\new Gain (Loss) on Extinguishment of Debt
Protagenic Therapeutics, Inc.\new (PTIX) reported Gain (Loss) on Extinguishment of Debt of -$1.12 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was -$1.14M.
- Protagenic Therapeutics, Inc.\new gain (loss) on extinguishment of debt for the quarter ending 2020-03-31 was -$5.86K.
- Protagenic Therapeutics, Inc.\new gain (loss) on extinguishment of debt for fiscal 2026 was -$1.12M.
- Protagenic Therapeutics, Inc.\new gain (loss) on extinguishment of debt for fiscal 2019 was -$99.54K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|
| 2026-03-31 | -$1.12M 10-K · filed 2026-08-14 | |
| 2025-06-30 | -$1.14M 10-Q · filed 2026-08-19 | |
| 2020-03-31 | -$5.86K 10-Q · filed 2021-05-17 | |
| 2019-12-31 | -$99.54K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |